Skip to main content

Table 1 Questionnaire results from the 16 participant centers

From: External Quality Assessment (EQA) program for the preanalytical and analytical immunohistochemical determination of HER2 in breast cancer: an experience on a regional scale

 

N (%)

N° annual HER2 determination

 

<100

4 (25%)

100-500

10 (62.5%)

>500

2 (12.5%)

Material

 

Paraffin embedded tissue

16 (100%)

Type of fixation

 

Buffered formalin

12 (75%)

Formalin

2 (12.5%)

Other

2 (12.5%)

Time of tissue fixation

 

12 hours

2 (12.5%)

24 hours

10 (62.5%)

Other

4 (25%)

Time from cutting to IHC

 

24 hours

10 (62.5%)

1 week

4 (25%)

other

2 (12.5%)

Slide storage

 

37°C

5 (31%)

Room temperature

11 (69%)

Immunostaining procedure

 

Automated

11 (69%)

Manual

5 (31%)

Type of reagent

 

A0485 PoAb

11 (69%)

CB11 MoAb

4 (25%)

Herceptest

1 (6%)

Chromogen

 

DAB

16 (100%)

Evaluation

 

Optical microscope

15 (94%)

Optical microscope + Image analyzer

1 (6%)

Evaluation criteria

 

Score and % of positive cells

10 (62.5%)

Score

6 (27.5%)